EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis

Aglaia Chalkia iD, Rachel Jones, Rona Smith, Lisa Willcocks, David Jayne

Clinical Kidney Journal · 07.01.2025 · 18 (1)

DOI: 10.1093/ckj/sfae379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 23.11.2024. Verfasst von Aglaia Chalkia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Cambridge, Cambridge, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Cambridge Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

It remains unclear whether persisting proteinuria in ANCA-associated glomerulonephritis (AAGN) reflects damage from the initial injury or ongoing inflammation.

Methods

A retrospective, single-centre study of biopsy-proven AAGN was performed. The study defined the ‘albuminuria’ group as urine albumin-to-creatinine ratio (ACR) >300 mg/g and the ‘no albuminuria’ group as ACR ≤300 mg/g at 6 months. We sought the clinical and histopathological characteristics of both the initial and subsequent biopsies and long-term kidney outcomes stratified by albuminuria levels.

Results

Two hundred and eighteen patients were included. Within the first 6 months, 28 (13%) died or progressed to end-stage kidney disease (ESKD). Among the remaining 190 patients, 37% had an ACR >300 mg/g at 6 months. The albuminuria group more frequently presented with a Berden mixed or crescentic class and had higher glomerular activity on the initial biopsy. They were more often male (OR 2.75; 95% CI 1.15–6.54), younger age (OR 0.96; 95% CI 0.93–0.99), and had fewer normal glomeruli in the biopsy (OR 0.96; 95% CI 0.93–0.99) compared with the group without albuminuria. Over the initial 5-year period, the recovery in eGFR was lower in the albuminuria group (adjusted mean difference in ΔeGFR −12.5 mL/min per 1.73 m2; 95% CI −15.8 to −9.1). In multivariable analysis, ACR >300 mg/g was associated with a higher risk of ESKD, even after adjusting for Berden classification and eGFR at diagnosis (hazard ratio 6.53; 95% CI 1.49–28.50).

Conclusions

In a well-defined cohort of AAGN, one-third of the patients, primarily younger males with a lower percentage of normal glomeruli, had persisting albuminuria after induction treatment which was associated with worse kidney outcomes independent of Berden class and eGFR at diagnosis.

Schlagwörter

Stichwörter der Autor:innen

ANCA-associated glomerulonephritisBerden classificationalbuminuriaend-stage kidney disease

Autor:innen und Institutionen

  • Department of Medicine, University of Cambridge, Cambridge, UK.
  • Vasculitis & Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK.

ORCID-Profile: Aglaia Chalkia

Förderung

  • NIHR Cambridge Biomedical Research Centre

Zitieren

APA

Chalkia, A., Jones, R., Smith, R., Willcocks, L., & Jayne, D. (2025). Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis. Clinical Kidney Journal, 18(1). https://doi.org/10.1093/ckj/sfae379

Vancouver

Chalkia A, Jones R, Smith R, Willcocks L, Jayne D. Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis. Clinical Kidney Journal. 2025;18(1). doi:10.1093/ckj/sfae379

BibTeX
@article{Chalkia2025,
  author = {Chalkia, Aglaia and Jones, Rachel and Smith, Rona and Willcocks, Lisa and Jayne, David},
  title = {Albuminuria after induction treatment and kidney prognosis in ANCA-associated glomerulonephritis},
  journal = {Clinical Kidney Journal},
  year = {2025},
  volume = {18},
  number = {1},
  doi = {10.1093/ckj/sfae379}
}
Kostenlos starten →